FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...

Microsoft, Chevron, 10x Genomics, 23andMe, NetApp, NGM Biopharmaceuticals, Pliant Therapeutics and Downtown College Prep are ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...

Following after is P-500, a selective, brain-penetrant PRMT5 inhibitor for advanced solid tumours, including high-grade ...

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

Leo Pharma is doing an extensive revamp of its leadership team as it splits product strategy and international operations ...

BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.